The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Suriname currently stands at 62%, indicating a decrease of 10% (-13.9%) since 2020.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Suriname
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Suriname
PMTCT antiretroviral therapy coverage
More indicators for Suriname
Male unintentional poisoning
0.3
0.0
(2019)
Female wasting in children
4.8%
+0.6%
(2018)
Female prevalence of HIV
0.3%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar229
-intl dollar2
(2021)
Birth registration
98.3%
-0.7%
(2018)
Contraceptive modern method prevalence
38.7%
-8.5%
(2018)
Suriname PMTCT antiretroviral therapy coverage between 2000 and 2021
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2021 | 62% | -10% |
| 2020 | 72% | +3% |
| 2019 | 69% | -3% |
| 2018 | 72% | -4% |
| 2017 | 76% | -10% |
| 2016 | 86% | -13% |
| 2015 | 99% | +8% |
| 2014 | 91% | +4% |
| 2013 | 87% | -2% |
| 2012 | 89% | -3% |
| 2011 | 92% | +29% |
| 2010 | 63% | -6% |
| 2009 | 69% | -3% |
| 2008 | 72% | -4% |
| 2007 | 76% | +20% |
| 2006 | 56% | +17% |
| 2005 | 39% | +25% |
| 2004 | 14% | +11% |
| 2003 | 3% | +3% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |